% alzhub.org library filter
% Source: https://alzhub.org/research?institution=I27804330&score_min=70
% 29 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{zimmer2025-40063015,
  author  = {Zimmer, J. A. and Ardayfio, P. and Wang, H. and Khanna, R. and Evans, C. D. and Lu, M. and Sparks, J. and Andersen, S. and Lauzon, S. and Nery, E. S. M. and others},
  title   = {{Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials}},
  journal = {JAMA Neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.0065},
  pmid    = {40063015},
  url     = {https://doi.org/10.1001/jamaneurol.2025.0065}
}

@article{salloway2022-34807243,
  author  = {Salloway, S. and Chalkias, S. and Barkhof, F. and Burkett, P. and Barakos, J. and Purcell, D. and Suhy, J. and Forrestal, F. and others},
  title   = {{Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2021.4161},
  pmid    = {34807243},
  url     = {https://doi.org/10.1001/jamaneurol.2021.4161}
}

@article{mcneil2018-30221597,
  author  = {McNeil, J. J. and Wolfe, R. and Woods, R. L. and Tonkin, A. M. and Donnan, G. A. and Nelson, M. R. and Reid, C. M. and Lockery, J. E. and others},
  title   = {{Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly}},
  journal = {The New England journal of medicine},
  year    = {2018},
  doi     = {10.1056/nejmoa1805819},
  pmid    = {30221597},
  url     = {https://doi.org/10.1056/nejmoa1805819}
}

@article{bateman2023-37966285,
  author  = {Bateman, R. J. and Smith, J. and Donohue, M. C. and Delmar, P. and Abbas, R. and Salloway, S. and Wojtowicz, J. and Blennow, K. and others},
  title   = {{Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2023},
  doi     = {10.1056/nejmoa2304430},
  pmid    = {37966285},
  url     = {https://doi.org/10.1056/nejmoa2304430}
}

@article{manson2013-24084921,
  author  = {Manson, J. E. and Chlebowski, R. T. and Stefanick, M. L. and Aragaki, A. K. and Rossouw, J. E. and Prentice, R. L. and Anderson, G. and Howard, B. V. and others},
  title   = {{Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials}},
  journal = {JAMA},
  year    = {2013},
  doi     = {10.1001/jama.2013.278040},
  pmid    = {24084921},
  url     = {https://doi.org/10.1001/jama.2013.278040}
}

@article{mintun2021-33720637,
  author  = {Mintun, M. A. and Lo, A. C. and Duggan Evans, C. and Wessels, A. M. and Ardayfio, P. A. and Andersen, S. W. and Shcherbinin, S. and Sparks, J. and others},
  title   = {{Donanemab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2021},
  doi     = {10.1056/nejmoa2100708},
  pmid    = {33720637},
  url     = {https://doi.org/10.1056/nejmoa2100708}
}

@article{bateman2012-22784036,
  author  = {Bateman, Randall John and Xiong, Chengjie and Benzinger, Tammie L.S. and Fagan, Anne M. and Goate, Alison and Fox, Nick C. and Marcus, Daniel S. and Cairns, Nigel J. and others},
  title   = {{Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease}},
  journal = {New England Journal of Medicine},
  year    = {2012},
  doi     = {10.1056/nejmoa1202753},
  pmid    = {22784036},
  url     = {https://doi.org/10.1056/nejmoa1202753}
}

@article{salloway2025-39556389,
  author  = {Salloway, S. and Wojtowicz, J. and Voyle, N. and Lane, C. A. and Klein, G. and Lyons, M. and Rossomanno, S. and Mazzo, F. and others},
  title   = {{Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2024.3937},
  pmid    = {39556389},
  url     = {https://doi.org/10.1001/jamaneurol.2024.3937}
}

@article{gordon2018-29397305,
  author  = {Gordon, B. A. and Blazey, T. M. and Su, Y. and Hari-Raj, A. and Dincer, A. and Flores, S. and Christensen, J. and McDade, E. and others},
  title   = {{Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study}},
  journal = {The Lancet. Neurology},
  year    = {2018},
  doi     = {10.1016/s1474-4422(18)30028-0},
  pmid    = {29397305},
  url     = {https://doi.org/10.1016/s1474-4422(18)30028-0}
}

@article{wang2025-40172303,
  author  = {Wang, H. and Serap Monkul Nery, E. and Ardayfio, P. and Khanna, R. and Otero Svaldi, D. and Gueorguieva, I. and Shcherbinin, S. and Andersen, S. W. and Hauck, P. M. and Engle, S. E. and others},
  title   = {{Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70062},
  pmid    = {40172303},
  url     = {https://doi.org/10.1002/alz.70062}
}

@article{rabinovici2019-30938796,
  author  = {Rabinovici, G. D. and Gatsonis, C. and Apgar, C. and Chaudhary, K. and Gareen, I. and Hanna, L. and Hendrix, J. and Hillner, B. E. and others},
  title   = {{Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia}},
  journal = {JAMA},
  year    = {2019},
  doi     = {10.1001/jama.2019.2000},
  pmid    = {30938796},
  url     = {https://doi.org/10.1001/jama.2019.2000}
}

@article{teno2013-23385273,
  author  = {Teno, J. M. and Gozalo, P. L. and Bynum, J. P. and Leland, N. E. and Miller, S. C. and Morden, N. E. and Scupp, T. and Goodman, D. C. and others},
  title   = {{Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009}},
  journal = {JAMA},
  year    = {2013},
  doi     = {10.1001/jama.2012.207624},
  pmid    = {23385273},
  url     = {https://doi.org/10.1001/jama.2012.207624}
}

@article{baker2025-40720610,
  author  = {Baker, L. D. and Espeland, M. A. and Whitmer, R. A. and Snyder, H. M. and Leng, X. and Lovato, L. and Papp, K. V. and Yu, M. and others},
  title   = {{Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2025},
  doi     = {10.1001/jama.2025.12923},
  pmid    = {40720610},
  url     = {https://doi.org/10.1001/jama.2025.12923}
}

@article{pottier2025-40280976,
  author  = {Pottier, Cyril P. and Küçükali, Fahri and Baker, Matt C. and Batzler, Anthony and Jenkins, Gregory D. and van Blitterswijk, Marka and Vicente, Cristina T. and De Coster, Wouter and others},
  title   = {{Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencing}},
  journal = {Nature Communications},
  year    = {2025},
  doi     = {10.1038/s41467-025-59216-0},
  pmid    = {40280976},
  url     = {https://doi.org/10.1038/s41467-025-59216-0}
}

@article{rabinovici2025-39776249,
  author  = {Rabinovici, G. D. and Knopman, D. S. and Arbizu, J. and Benzinger, T. L. S. and Donohoe, K. J. and Hansson, O. and Herscovitch, P. and Kuo, P. H. and Lingler, J. H. and Minoshima, S. and others},
  title   = {{Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.14338},
  pmid    = {39776249},
  url     = {https://doi.org/10.1002/alz.14338}
}

@article{preische2019-30664784,
  author  = {Preische, O. and Schultz, S. A. and Apel, A. and Kuhle, J. and Kaeser, S. A. and Barro, C. and Gräber, S. and others},
  title   = {{Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease}},
  journal = {Nature medicine},
  year    = {2019},
  doi     = {10.1038/s41591-018-0304-3},
  pmid    = {30664784},
  url     = {https://doi.org/10.1038/s41591-018-0304-3}
}

@article{wilkins2022-36190710,
  author  = {Wilkins, C. H. and Windon, C. C. and Dilworth-Anderson, P. and Romanoff, J. and Gatsonis, C. and Hanna, L. and Apgar, C. and Gareen, I. F. and others},
  title   = {{Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort Study}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.3157},
  pmid    = {36190710},
  url     = {https://doi.org/10.1001/jamaneurol.2022.3157}
}

@article{sims2023-37459141,
  author  = {Sims, JR. and Zimmer, J. A. and Evans, C. D. and Lu, M. and Ardayfio, P. and Sparks, J. and Wessels, A. M. and Shcherbinin, S. and others},
  title   = {{Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2023},
  doi     = {10.1001/jama.2023.13239},
  pmid    = {37459141},
  url     = {https://doi.org/10.1001/jama.2023.13239}
}

@article{salloway2004-15326237,
  author  = {Salloway, S. and Ferris, S. and Kluger, A. and Goldman, R. and Griesing, T. and Kumar, D. and Richardson, S. and {Donepezil 401 Study Group}},
  title   = {{Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial}},
  journal = {Neurology},
  year    = {2004},
  doi     = {10.1212/01.wnl.0000134664.80320.92},
  pmid    = {15326237},
  url     = {https://doi.org/10.1212/01.wnl.0000134664.80320.92}
}

@article{coric2015-26414022,
  author  = {Coric, V. and Salloway, S. and van Dyck, C. H. and Dubois, B. and Andreasen, N. and Brody, M. and Curtis, C. and Soininen, H. and others},
  title   = {{Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2015.0607},
  pmid    = {26414022},
  url     = {https://doi.org/10.1001/jamaneurol.2015.0607}
}

@article{mummery2026-41787076,
  author  = {Mummery, C. J. and Mayorga, A. J. and Simmons, A. and Chow, T. W. and Burgess, B. and Nguyen, T. and Gao, J. and Budda, B. and Park, L. Q. and Gupta, R. and Li, C. and Shi, L. and others},
  title   = {{The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trial}},
  journal = {Nature Medicine},
  year    = {2026},
  doi     = {10.1038/s41591-026-04273-1},
  pmid    = {41787076},
  url     = {https://doi.org/10.1038/s41591-026-04273-1}
}

@article{peskind2006-16861375,
  author  = {Peskind, E. R. and Potkin, S. G. and Pomara, N. and Ott, B. R. and Graham, S. M. and Olin, J. T. and McDonald, S.},
  title   = {{Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2006},
  doi     = {10.1097/01.jgp.0000224350.82719.83},
  pmid    = {16861375},
  url     = {https://doi.org/10.1097/01.jgp.0000224350.82719.83}
}

@article{devanand2026-41405855,
  author  = {Devanand, D P and Wisniewski, Thomas and Razlighi, Qolamreza and Qian, Min and Wei, Renjie and Andrews, Howard F and Acosta, Edward P and Bell, Karen L and others},
  title   = {{Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2026},
  doi     = {10.1001/jama.2025.21738},
  pmid    = {41405855},
  url     = {https://doi.org/10.1001/jama.2025.21738}
}

@article{coe2026-41669119,
  author  = {Coe, Norma B. and Miller, Katherine E. M. and Sun, Chuxuan and Taggert, Elizabeth and Gross, Alden L. and Jones, Richard Norman and Felix, Cynthia and Albert, Marilyn S. and others},
  title   = {{Impact of cognitive training on claims‐based diagnosed dementia over 20 years: evidence from the ACTIVE study}},
  journal = {Alzheimer s \& Dementia Translational Research \& Clinical Interventions},
  year    = {2026},
  doi     = {10.1002/trc2.70197},
  pmid    = {41669119},
  url     = {https://doi.org/10.1002/trc2.70197}
}

@article{manly2022-36279130,
  author  = {Manly, J. J. and Jones, R. N. and Langa, K. M. and Ryan, L. H. and Levine, D. A. and McCammon, R. and Heeringa, S. G. and Weir, D.},
  title   = {{Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US: The 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol Project}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.3543},
  pmid    = {36279130},
  url     = {https://doi.org/10.1001/jamaneurol.2022.3543}
}

@article{curtis2015-25622185,
  author  = {Curtis, C. and Gamez, J. E. and Singh, U. and Sadowsky, C. H. and Villena, T. and Sabbagh, M. N. and Beach, T. G. and Duara, R. and others},
  title   = {{Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2014.4144},
  pmid    = {25622185},
  url     = {https://doi.org/10.1001/jamaneurol.2014.4144}
}

@article{lozano2016-27567810,
  author  = {Lozano, A. M. and Fosdick, L. and Chakravarty, M. M. and Leoutsakos, J. M. and Munro, C. and Oh, E. and Drake, K. E. and Lyman, C. H. and others},
  title   = {{A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2016},
  doi     = {10.3233/jad-160017},
  pmid    = {27567810},
  url     = {https://doi.org/10.3233/jad-160017}
}

@article{hu2022-35446396,
  author  = {Hu, Y. and Kirmess, K. M. and Meyer, M. R. and Rabinovici, G. D. and Gatsonis, C. and Siegel, B. A. and Whitmer, R. A. and Apgar, C. and others},
  title   = {{Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment}},
  journal = {JAMA network open},
  year    = {2022},
  doi     = {10.1001/jamanetworkopen.2022.8392},
  pmid    = {35446396},
  url     = {https://doi.org/10.1001/jamanetworkopen.2022.8392}
}

@article{dube2019-31591557,
  author  = {Dube, U. and Del-Aguila, J. L. and Li, Z. and Budde, J. P. and Jiang, S. and Hsu, S. and Ibanez, L. and Fernandez, M. V. and others},
  title   = {{An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations}},
  journal = {Nature neuroscience},
  year    = {2019},
  doi     = {10.1038/s41593-019-0501-5},
  pmid    = {31591557},
  url     = {https://doi.org/10.1038/s41593-019-0501-5}
}